Korea University at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

Korea University brings 2 presentations to IDWeek 2026 in Washington. Its program spans carbapenem resistance and HIV treatment. One study finds that outer membrane vesicles create conditions that favor mutations and carbapenem resistance without KPC gene transfer, and another examines how comorbidities shape antiretroviral choices nationwide in South Korea.

OrganizationIDWeek 2026 Attendance
Korea University
Seoul, South Korea
Poster
Thu Oct 22
12:15pm–1:30pm
OMV-driven mutation-permissive environments facilitate carbapenem resistance independent of blaKPC transfer
Poster Hall B-C · Poster P-64
A3. Resistance mechanisms
Poster
Fri Oct 23
12:15pm–1:30pm
Comorbidity-Driven Antiretroviral Therapy Selection in the INSTI Era: A Nationwide South Korean Study
Poster Hall B-C · Poster P-1004
H4. HIV: Treatment

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Korea University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction